GFAP and Alzheimer disease: Plasma glial fibrillary acidic protein (GFAP) and plasma pTau‐217 levels were compared by AD pathophysiology (amyloid (A+) and tau (T+) positron emission tomography [PET]) in persons with DS (N = 348) and sibling controls (N = 42).